Republican investigators wanted to know where the six-foot rule came from. In a closed-door session on January 8, 2024, they pressed Anthony Fauci on the origins of social distancing. His answer, recorded in the transcript released by the House Oversight Committee: "It sort of just appeared."

Fourteen hours over two days. The terrain was origin stories for public health guidance, memory tests for emails sent in March 2020, the granular reconstruction of bureaucratic decisions made under conditions no one understood.

The House Select Subcommittee on the Coronavirus Pandemic had summoned the former NIAID director as witness. The exercise was institutional autopsy. By the time Fauci appeared, he had already been stripped of the title he held for thirty-eight years. His successor, Dr. Jeanne Marrazzo, was herself operating under legal challenge. House Republicans had questioned her appointment in an August 2023 letter that cited constitutional appointment procedures allegedly violated. The letter noted that since the 21st Century Cures Act, HHS Secretaries had "personally approved" such appointments. Marrazzo's had not followed this precedent.

The procedural attack was precise. A separate House Energy and Commerce investigation found that Fauci and thirteen other NIH institute directors had served for eighteen months after their terms expired in December 2021. Their reappointment affidavits were not signed until June 2023. The finding carried material weight. More than $25 billion in research grants from 2022 alone were potentially jeopardized by questions about the legal validity of decisions made by officials serving in expired positions.

This was not traditional oversight. The investigation located vulnerability in the architecture itself: appointment procedures, term limits, chains of authorization. It exploited them. The effect, intentional or not, was to demonstrate that the nation's premier biomedical research agency could be legally encircled, its operations suspended in procedural doubt.

Public confidence in the NIH dropped from 74% to 62% between September 2024 and August 2025, a twelve-point decline concentrated among Democrats who had previously maintained institutional trust. Republican confidence had already cratered. YouGov polling found trust in Fauci's medical advice among Republicans fell from 56% in March 2020 to 48% by April 2020, with distrust rising from 5% to 23%. This was before the first vaccine. Before the first mask mandate. Before "Fauci-ing" entered the dating lexicon.

The Atlantic's recent profile captures the personal arc: the security detail, the death threats, the transformation from trusted physician to cultural totem. What it underweights is the structural inheritance. By the time Fauci retired, he had become proof of concept for a new political technology. The systematic dismantling of scientific authority through institutional lawfare, performed slowly enough to claim procedural legitimacy and thoroughly enough to discourage successors.

The mechanism has since accelerated. Politico reported in April 2025 that Fauci allies and vaccine officials were dismissed from NIH, with political appointees replacing career scientists in hiring decisions. Undark's institutional analysis traced compressed hiring timelines and expanded political control over directorships. The agency Fauci built his career within is being restructured around the assumption that his tenure was an aberration requiring correction.

Fauci himself, in a June 2025 WBUR interview, described the atmosphere he left behind: "The morale at the NIH is just gloomy. They feel intimidated." The observation carries weight from a man who began his career during the AIDS crisis, when scientific institutions faced moral rather than political opposition. The difference matters. Activists demanding faster drug approval were adversaries who shared a goal. Congressional investigators demanding email archives are dismantlers of the infrastructure itself.

The testimony poses a question it does not answer. What institutional design could survive similar treatment? The NIH was constructed with assumptions about scientific autonomy that presumed bipartisan consensus on the value of expertise itself. That consensus proved thinner than its architecture required. The appointment procedures now being weaponized were designed for administrative efficiency, not political hardening. An agency built for cooperation now faces opposition determined to legally paralyze it without changing a single statute.

Marrazzo's NIAID operates under these conditions, as will her successors. The directorship that Fauci held from 1984 to 2022 is now a position defined by its vulnerability. Its occupant is subject to retrospective investigation, its decisions to legal challenge, its funding to political determination. The next pandemic will find this structure in place: scientific leadership as precarious appointment, expertise as contested terrain, the six-foot rule not merely questioned but legally unmoored.

The transcript records Fauci's final exchange with investigators. They asked about masks, about school closures, about origins and funding and emails. He answered as he could. The document runs 446 pages. It documents fragility: the ease with which institutional authority converts to institutional exposure, and the price that conversion exacts from the next director who must decide under fire.